4796 related articles for article (PubMed ID: 3159801)
1. Analysis of major histocompatibility antigens and the mononuclear cell infiltrate in halo nevi.
Bergman W; Willemze R; de Graaff-Reitsma C; Ruiter DJ
J Invest Dermatol; 1985 Jul; 85(1):25-9. PubMed ID: 3159801
[TBL] [Abstract][Full Text] [Related]
2. Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma.
Ruiter DJ; Bhan AK; Harrist TJ; Sober AJ; Mihm MC
J Immunol; 1982 Dec; 129(6):2808-15. PubMed ID: 6183345
[TBL] [Abstract][Full Text] [Related]
3. Halo congenital nevus undergoing spontaneous regression. Involvement of T-cell immunity in involution and presence of circulating anti-nevus cell IgM antibodies.
Tokura Y; Yamanaka K; Wakita H; Kurokawa S; Horiguchi D; Usui A; Sayama S; Takigawa M
Arch Dermatol; 1994 Aug; 130(8):1036-41. PubMed ID: 8053701
[TBL] [Abstract][Full Text] [Related]
4. In situ analysis of the mononuclear cell infiltrate in primary malignant melanoma of the skin.
Poppema S; Bröcker EB; de Leij L; Terbrack D; Visscher T; Ter Haar A; Macher E; Thé TH; Sorg C
Clin Exp Immunol; 1983 Jan; 51(1):77-82. PubMed ID: 6219841
[TBL] [Abstract][Full Text] [Related]
5. The immune response in halo nevi.
Zeff RA; Freitag A; Grin CM; Grant-Kels JM
J Am Acad Dermatol; 1997 Oct; 37(4):620-4. PubMed ID: 9344203
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens.
Ruiter DJ; Bergman W; Welvaart K; Scheffer E; van Vloten WA; Russo C; Ferrone S
Cancer Res; 1984 Sep; 44(9):3930-5. PubMed ID: 6204749
[TBL] [Abstract][Full Text] [Related]
7. Immunopathology of renal allograft rejection analyzed with monoclonal antibodies to mononuclear cell markers.
Bishop GA; Hall BM; Duggin GG; Horvath JS; Sheil AG; Tiller DJ
Kidney Int; 1986 Mar; 29(3):708-17. PubMed ID: 2939279
[TBL] [Abstract][Full Text] [Related]
8. Beta 2 microglobulin expression in normal melanocytes, nevocellular nevi, and malignant melanomas.
Takata M; Hirone T; Matsumura H
J Invest Dermatol; 1989 May; 92(5 Suppl):243S-247S. PubMed ID: 2654298
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the mononuclear infiltrate involved in regression of halo nevi.
Akasu R; From L; Kahn HJ
J Cutan Pathol; 1994 Aug; 21(4):302-11. PubMed ID: 7798386
[TBL] [Abstract][Full Text] [Related]
10. Melanocytic atypia in dysplastic nevi. Immunohistochemical and cytophotometrical analysis.
Bergman W; Ruiter DJ; Scheffer E; van Vloten WA
Cancer; 1988 Apr; 61(8):1660-6. PubMed ID: 3349425
[TBL] [Abstract][Full Text] [Related]
11. Immune-mediated destruction of melanocytes in halo nevi is associated with the local expansion of a limited number of T cell clones.
Musette P; Bachelez H; Flageul B; Delarbre C; Kourilsky P; Dubertret L; Gachelin G
J Immunol; 1999 Feb; 162(3):1789-94. PubMed ID: 9973443
[TBL] [Abstract][Full Text] [Related]
12. Immunohistological evaluation of MHC class I and II antigen expression on nevi and melanoma: relation to biology of melanoma.
D'Alessandro G; Zardawi I; Grace J; McCarthy WH; Hersey P
Pathology; 1987 Oct; 19(4):339-46. PubMed ID: 3328139
[TBL] [Abstract][Full Text] [Related]
13. Congenital melanocytic nevi with halo phenomenon: report of two cases and a review of the literature.
Langer K; Konrad K
J Dermatol Surg Oncol; 1990 Apr; 16(4):377-80. PubMed ID: 2182687
[TBL] [Abstract][Full Text] [Related]
14. HLA antigen expression in melanocytic lesions: is acquisition of HLA antigen expression a biomarker of atypical (dysplastic) melanocytes?
Campoli M; Fitzpatrick JE; High W; Ferrone S
J Am Acad Dermatol; 2012 Jun; 66(6):911-6, 916.e1-8. PubMed ID: 22445792
[TBL] [Abstract][Full Text] [Related]
15. HLA-DR antigen expression in primary melanomas of the skin.
Bröcker EB; Suter L; Sorg C
J Invest Dermatol; 1984 Mar; 82(3):244-7. PubMed ID: 6366074
[TBL] [Abstract][Full Text] [Related]
16. Expression of major histocompatibility antigens and nature of inflammatory cellular infiltrate in ovarian neoplasms.
Kabawat SE; Bast RC; Welch WR; Knapp RC; Bhan AK
Int J Cancer; 1983 Nov; 32(5):547-54. PubMed ID: 6358053
[TBL] [Abstract][Full Text] [Related]
17. Immunohistologic characterization of major histocompatibility antigens and inflammatory cellular infiltrate in human breast cancer.
Bhan AK; DesMarais CL
J Natl Cancer Inst; 1983 Sep; 71(3):507-16. PubMed ID: 6193308
[TBL] [Abstract][Full Text] [Related]
18. [Halo nevus. In situ study using monoclonal antibodies].
Vignale RA; Paciel J; Bruno J; Calandría L; de Anda G
Med Cutan Ibero Lat Am; 1986; 14(1):13-7. PubMed ID: 2942737
[TBL] [Abstract][Full Text] [Related]
19. Study of the immunophenotype of the inflammatory cells in melanomas with regression and halo nevi.
Botella-Estrada R; Kutzner H
Am J Dermatopathol; 2015 May; 37(5):376-80. PubMed ID: 25222195
[TBL] [Abstract][Full Text] [Related]
20. The influence of allogeneic cells on the human T and B cell repertoire.
van Rood JJ; Claas FH
Science; 1990 Jun; 248(4961):1388-93. PubMed ID: 1972596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
